Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers

Ignacio Moraga, Jamie B. Spangler, Juan L. Mendoza, Milica Gakovic, Tom S. Wehrman, Peter Krutzik, K. Christopher Garcia

Research output: Contribution to journalArticle

7 Citations (Scopus)
5 Downloads (Pure)

Abstract

Cytokine and growth-factor ligands typically signal through homo- or hetero-dimeric cell surface receptors via Janus Kinase (JAK/TYK), or Receptor Tyrosine Kinase (RTK)-mediated trans-phosphorylation. However, the number of receptor dimer pairings occurring in nature is limited to those driven by natural ligands encoded within our genome. We have engineered synthethic cytokines (synthekines) that drive formation of cytokine receptor dimer pairings that are not formed by endogenous cytokines and that are not found in nature, and which activate distinct signaling programs. We show that a wide range of non-natural cytokine receptor hetero-dimers are competent to elicit a signaling output. We engineered synthekine ligands that assembled IL-2Rb/IL-4Ra or IL-4Ra/IFNAR2 receptor heterodimers, that do not occur naturally, triggering signaling and functional responses distinct from those activated by the endogenous cytokines IL-2, IL-4, and IFN. Furthermore, hybrid synthekine ligands that dimerized a JAK/STAT cytokine receptor with a receptor tyrosine kinase (RTK) also elicited a signaling response. Synthekines represent a new family of synthetic ligands with pre-defined receptors, but ’orphan’ functions, that enable the full combinatorial scope of dimeric signaling receptors encoded within the human genome to be exploited for basic research and drug discovery.

Original languageEnglish
Article numbere22882
JournaleLife
Volume6
DOIs
Publication statusPublished - 12 May 2017

Fingerprint

Dimers
Intercellular Signaling Peptides and Proteins
Cytokine Receptors
Cytokines
Ligands
Receptor Protein-Tyrosine Kinases
Genes
Janus Kinases
Phosphorylation
Cell Surface Receptors
Human Genome
Drug Discovery
Interleukin-4
Interleukin-2
Genome
Research

Cite this

Moraga, Ignacio ; Spangler, Jamie B. ; Mendoza, Juan L. ; Gakovic, Milica ; Wehrman, Tom S. ; Krutzik, Peter ; Garcia, K. Christopher. / Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. In: eLife. 2017 ; Vol. 6.
@article{e6ef2e93a51141ad84aad8253938f3ba,
title = "Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers",
abstract = "Cytokine and growth-factor ligands typically signal through homo- or hetero-dimeric cell surface receptors via Janus Kinase (JAK/TYK), or Receptor Tyrosine Kinase (RTK)-mediated trans-phosphorylation. However, the number of receptor dimer pairings occurring in nature is limited to those driven by natural ligands encoded within our genome. We have engineered synthethic cytokines (synthekines) that drive formation of cytokine receptor dimer pairings that are not formed by endogenous cytokines and that are not found in nature, and which activate distinct signaling programs. We show that a wide range of non-natural cytokine receptor hetero-dimers are competent to elicit a signaling output. We engineered synthekine ligands that assembled IL-2Rb/IL-4Ra or IL-4Ra/IFNAR2 receptor heterodimers, that do not occur naturally, triggering signaling and functional responses distinct from those activated by the endogenous cytokines IL-2, IL-4, and IFN. Furthermore, hybrid synthekine ligands that dimerized a JAK/STAT cytokine receptor with a receptor tyrosine kinase (RTK) also elicited a signaling response. Synthekines represent a new family of synthetic ligands with pre-defined receptors, but ’orphan’ functions, that enable the full combinatorial scope of dimeric signaling receptors encoded within the human genome to be exploited for basic research and drug discovery.",
author = "Ignacio Moraga and Spangler, {Jamie B.} and Mendoza, {Juan L.} and Milica Gakovic and Wehrman, {Tom S.} and Peter Krutzik and Garcia, {K. Christopher}",
year = "2017",
month = "5",
day = "12",
doi = "10.7554/eLife.22882",
language = "English",
volume = "6",
journal = "eLife",
issn = "2050-084X",
publisher = "eLife Sciences Publications Ltd.",

}

Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. / Moraga, Ignacio; Spangler, Jamie B.; Mendoza, Juan L.; Gakovic, Milica; Wehrman, Tom S.; Krutzik, Peter; Garcia, K. Christopher.

In: eLife, Vol. 6, e22882, 12.05.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers

AU - Moraga, Ignacio

AU - Spangler, Jamie B.

AU - Mendoza, Juan L.

AU - Gakovic, Milica

AU - Wehrman, Tom S.

AU - Krutzik, Peter

AU - Garcia, K. Christopher

PY - 2017/5/12

Y1 - 2017/5/12

N2 - Cytokine and growth-factor ligands typically signal through homo- or hetero-dimeric cell surface receptors via Janus Kinase (JAK/TYK), or Receptor Tyrosine Kinase (RTK)-mediated trans-phosphorylation. However, the number of receptor dimer pairings occurring in nature is limited to those driven by natural ligands encoded within our genome. We have engineered synthethic cytokines (synthekines) that drive formation of cytokine receptor dimer pairings that are not formed by endogenous cytokines and that are not found in nature, and which activate distinct signaling programs. We show that a wide range of non-natural cytokine receptor hetero-dimers are competent to elicit a signaling output. We engineered synthekine ligands that assembled IL-2Rb/IL-4Ra or IL-4Ra/IFNAR2 receptor heterodimers, that do not occur naturally, triggering signaling and functional responses distinct from those activated by the endogenous cytokines IL-2, IL-4, and IFN. Furthermore, hybrid synthekine ligands that dimerized a JAK/STAT cytokine receptor with a receptor tyrosine kinase (RTK) also elicited a signaling response. Synthekines represent a new family of synthetic ligands with pre-defined receptors, but ’orphan’ functions, that enable the full combinatorial scope of dimeric signaling receptors encoded within the human genome to be exploited for basic research and drug discovery.

AB - Cytokine and growth-factor ligands typically signal through homo- or hetero-dimeric cell surface receptors via Janus Kinase (JAK/TYK), or Receptor Tyrosine Kinase (RTK)-mediated trans-phosphorylation. However, the number of receptor dimer pairings occurring in nature is limited to those driven by natural ligands encoded within our genome. We have engineered synthethic cytokines (synthekines) that drive formation of cytokine receptor dimer pairings that are not formed by endogenous cytokines and that are not found in nature, and which activate distinct signaling programs. We show that a wide range of non-natural cytokine receptor hetero-dimers are competent to elicit a signaling output. We engineered synthekine ligands that assembled IL-2Rb/IL-4Ra or IL-4Ra/IFNAR2 receptor heterodimers, that do not occur naturally, triggering signaling and functional responses distinct from those activated by the endogenous cytokines IL-2, IL-4, and IFN. Furthermore, hybrid synthekine ligands that dimerized a JAK/STAT cytokine receptor with a receptor tyrosine kinase (RTK) also elicited a signaling response. Synthekines represent a new family of synthetic ligands with pre-defined receptors, but ’orphan’ functions, that enable the full combinatorial scope of dimeric signaling receptors encoded within the human genome to be exploited for basic research and drug discovery.

UR - http://www.scopus.com/inward/record.url?scp=85019455363&partnerID=8YFLogxK

U2 - 10.7554/eLife.22882

DO - 10.7554/eLife.22882

M3 - Article

C2 - 28498099

AN - SCOPUS:85019455363

VL - 6

JO - eLife

JF - eLife

SN - 2050-084X

M1 - e22882

ER -